Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Sacharczuk, , Aniela,
DOB: 02-NOV-1970 (Age: 55)
Gender: female
Address:
plac Szpitalna 13
27-600 Sandomierz (Poland)
ID: 3843-787162-7 (ECI)
Report
Date: 27-DEC-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ośrodek Zdrowia
Józefa Piłsudskiego 17
39-432 Gorzyce (Poland)
Specimen
Collected: 27-DEC-2022

Chemistry

Test 27-DEC-2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 78.3 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 103.6 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 26.1 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 171.3 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 146.2 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 82.8 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 59.3 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All results are within normal limits except for a mildly elevated HbA1c (6.0%), indicating prediabetes, and triglycerides at the upper normal limit. Renal function, electrolytes, and lipid profile are otherwise unremarkable. Recommend lifestyle modification and follow-up for glycemic control. No acute laboratory concerns.